EUROFINS ADVINUS BIOPHARMA

Manufacturer

Eurofins Advinus Biopharma is a leading Contract Research, Development, and Manufacturing Organization (CRDMO) based in India, operating as a key entity within the global Eurofins Scientific network. The company functions as a manufacturer, providing comprehensive, integrated services to pharmaceutical and biotechnology clients worldwide.

Specializing in biopharmaceutical development and manufacturing, Eurofins Advinus Biopharma offers a broad spectrum of services that span the drug discovery and development lifecycle. Its core offerings include:

Preclinical Research: Extensive capabilities in drug safety assessment, toxicology studies, pharmacokinetics (PK), and pharmacodynamics (PD) to support drug candidates from early discovery stages through to regulatory submissions.

Biopharmaceutical Development: Expertise in cell line development, upstream and downstream process development, formulation development, and advanced analytical method development for various biologics.

Biomanufacturing: State-of-the-art facilities equipped for the Good Manufacturing Practice (GMP) compliant production of biologics, catering to both clinical trial supply (Phase I, II, III) and commercial manufacturing needs.

With its primary operations in Bengaluru, India, Eurofins Advinus Biopharma is distinguished by its scientific acumen, advanced technological infrastructure, and unwavering commitment to quality, regulatory compliance, and client success in accelerating the development and market entry of novel biotherapeutics.

EUROFINS ADVINUS BIOPHARMA in India primarily offers a comprehensive range of contract research and development services to the pharmaceutical, biopharmaceutical, and chemical industries. These services, which are their core offerings or 'products' in the context of their business, include:

1. Drug Discovery Services including medicinal chemistry, discovery biology, and in vitro ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) studies.

2. Preclinical Toxicology and Safety Assessment Studies, conducted under GLP (Good Laboratory Practice) and non-GLP conditions, covering acute, sub-chronic, chronic, reproductive, and genetic toxicology.

3. Pharmacokinetics and Pharmacodynamics Studies to understand drug absorption, distribution, metabolism, excretion, and mechanism of action.

4. Bioanalytical Services utilizing advanced techniques like LC-MS/MS for quantification of drugs and metabolites in biological matrices.

5. Chemistry Services such as custom synthesis, process chemistry development and scale-up, and analytical chemistry support including impurity profiling, method development, and validation.

6. Regulatory Affairs Support for various stages of drug development.